Form 4: Alignment Healthcare Director Joseph Konowiecki Sells Shares in Two-Day Span

Director Joseph Konowiecki sold 50,000 shares of Alignment Healthcare (ALHC) common stock over two days, September 12th and 13th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), sold 25,000 shares of common stock on September 12, 2024, at a weighted average price of $11.0037 per share.
• The sales occurred under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2024.
• Following the transaction on September 12, Konowiecki directly owned 1,183,221 shares of ALHC common stock.
• On September 13, 2024, Konowiecki sold another 25,000 shares at a weighted average price of $12.0005 per share.
• After the second transaction, Konowiecki directly owned 1,158,221 shares of ALHC common stock.
• The sales were executed in multiple transactions within price ranges of $11.00 to $11.0685 and $12.00 to $12.01 on September 12 and 13 respectively.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports facts without expressing any opinion or judgment.

Industry Context

Insider sales are a common occurrence, and the use of a pre-arranged Rule 10b5-1 trading plan suggests the sales were planned in advance and not based on any specific non-public information.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in stock price.

Key Dates